Nuvo Drug Patent Portfolio
Nuvo owns 3 orange book drugs protected by 10 US patents Given below is the list of Nuvo's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8546450 | Treatment of pain with topical diclofenac compounds | 09 Aug, 2030 | Active |
| US8217078 | Treatment of pain with topical diclofenac | 10 Jul, 2029 | Active |
| US8618164 | Treatment of pain with topical diclofenac compounds | 10 Jul, 2029 | Active |
| US8741956 | Treatment of pain with topical diclofenac | 10 Jul, 2029 | Active |
| US7132570 | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil | 18 Jun, 2024 | Expired |
| US7297346 | Pharmaceutical formulations of modafinil | 29 May, 2024 | Expired |
| US7132570 | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil | 18 Dec, 2023 | Expired |
| US7297346 | Pharmaceutical formulations of modafinil | 29 Nov, 2023 | Expired |
| USRE37516 | Acetamide derivative having defined particle size | 06 Apr, 2015 | Expired |
| USRE37516 | Acetamide derivative having defined particle size | 06 Oct, 2014 | Expired |
Latest Legal Activities on Nuvo's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Nuvo.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 24 Jun, 2024 | US9339551 (Litigated) |
|
Expire Patent
Critical
| 24 Jun, 2024 | US9339552 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 15 Apr, 2024 | US8252838 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Apr, 2024 | US9415029 |
|
Maintenance Fee Reminder Mailed
Critical
| 26 Feb, 2024 | US8217078 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 19 Feb, 2024 | US9375412 |
|
Maintenance Fee Reminder Mailed
Critical
| 12 Feb, 2024 | US9370501 |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Jan, 2024 | US9339552 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Jan, 2024 | US9339551 (Litigated) |
|
Expire Patent
Critical
| 23 Oct, 2023 | US9132110 (Litigated) |
|
Expire Patent
Critical
| 18 Sep, 2023 | US9101591 (Litigated) |
|
Expire Patent
Critical
| 07 Aug, 2023 | US9066913 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Jun, 2023 | US9220784 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 08 May, 2023 | US9132110 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 27 Apr, 2023 | US9168304 (Litigated) |
Nuvo's Family Patents
Nuvo Drug List
Given below is the complete list of Nuvo's drugs and the patents protecting them.
1. Nuvigil
Nuvigil is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7132570
(Pediatric)
| Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
18 Jun, 2024
(1 year, 6 months ago)
| Expired |
| US7297346
(Pediatric)
| Pharmaceutical formulations of modafinil |
29 May, 2024
(1 year, 7 months ago)
| Expired |
| US7132570 | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
18 Dec, 2023
(2 years ago)
| Expired |
| US7297346 | Pharmaceutical formulations of modafinil |
29 Nov, 2023
(2 years ago)
| Expired |
| USRE37516
(Pediatric)
| Acetamide derivative having defined particle size |
06 Apr, 2015
(10 years ago)
| Expired |
| USRE37516 | Acetamide derivative having defined particle size |
06 Oct, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nuvigil's drug page
2. Pennsaid
Pennsaid is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8546450 | Treatment of pain with topical diclofenac compounds |
09 Aug, 2030
(4 years from now)
| Active |
| US8217078 | Treatment of pain with topical diclofenac |
10 Jul, 2029
(3 years from now)
| Active |
| US8618164 | Treatment of pain with topical diclofenac compounds |
10 Jul, 2029
(3 years from now)
| Active |
| US8741956 | Treatment of pain with topical diclofenac |
10 Jul, 2029
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pennsaid's drug page
3. Provigil
Provigil is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7297346
(Pediatric)
| Pharmaceutical formulations of modafinil |
29 May, 2024
(1 year, 7 months ago)
| Expired |
| US7297346 | Pharmaceutical formulations of modafinil |
29 Nov, 2023
(2 years ago)
| Expired |
| USRE37516
(Pediatric)
| Acetamide derivative having defined particle size |
06 Apr, 2015
(10 years ago)
| Expired |
| USRE37516 | Acetamide derivative having defined particle size |
06 Oct, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Provigil's drug page